Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
Naureen KericHarald KrenzlinDarius KalasauskasChristian F FreyschlagOliver SchnellMartin MischChristian von der BrelieJens GemptAleksandrs KrigersArthur WagnerFelipa LangeDorothee MielkeClemens SommerMarc A BrockmannBernhard MeyerVeit RohdePeter VajkoczyJürgen BeckClaudius ThoméFlorian RingelPublished in: Journal of neuro-oncology (2024)
WHO grade 2 and 3 IDH1/2 wt astrocytomas, treated according to the same treatment protocols, have a similar OS. Age, extent of resection, and strong EGFR expression were the most important treatment related prognostic factors.